Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism
Investigative Ophthalmology & Visual Science · 20.08.2024 · 65 (10) · 26
DOI: 10.1167/iovs.65.10.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 20.08.2024. Verfasst von Quincy C C van den Bosch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Zebrafish, Uveal Neoplasms, Melanoma, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Uveal melanoma (UM) is the most common primary intraocular malignancy with a high probability of metastatic disease. Although excellent treatment options for primary UM are available, therapy for metastatic disease remain limited. Drug discovery studies using mouse models have thus far failed to provide therapeutic solutions, highlighting the need for novel models. Here, we optimize zebrafish xenografts as a potential model for drug discovery by showcasing the behavior of multiple cell lines and novel findings on mutation-dependent compound synergism/antagonism using Z-Tada; an algorithm to objectively characterize output measurements.
Methods
Prognostic relevant primary (N = 4) and metastatic UM (N = 1) cell lines or healthy melanocytes (N = 2) were inoculated at three distinct inoculation sites. Standardized quantifications independent of inoculation site were obtained using Z-Tada; an algorithm to measure tumor burden and the number, size, and distance of disseminated tumor cells. Sequentially, we utilized this model to validate combinatorial synergism or antagonism seen in vitro.
Results
Detailed analysis of 691 zebrafish xenografts demonstrated perivitelline space inoculation provided robust data with high probability of cell dissemination. Cell lines with more invasive behavior (SF3B1mut and BAP1mut) behaved most aggressive in this model. Combinatorial drug treatment illustrated synergism or antagonism is mutation-dependent, which were confirmed in vivo. Combinatorial treatment differed per xenograft-model, as it either inhibited overall tumor burden or cell dissemination.
Conclusions
Perivitelline space inoculation provides robust zebrafish xenografts with the ability for high-throughput drug screening and robust data acquisition using Z-Tada. This model demonstrates that drug discovery for uveal melanoma must take mutational subclasses into account, especially in combinatorial treatment discoveries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
- Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Zitieren
APA
van den Bosch, Q. C. C., Kiliç, E., & Brosens, E. (2024). Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism. Investigative Ophthalmology & Visual Science, 65(10), 26. https://doi.org/10.1167/iovs.65.10.26
Vancouver
van den Bosch QCC, Kiliç E, Brosens E. Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism. Investigative Ophthalmology & Visual Science. 2024;65(10):26. doi:10.1167/iovs.65.10.26
BibTeX
@article{vandenBosch2024,
author = {van den Bosch, Quincy C C and Kiliç, Emine and Brosens, Erwin},
title = {Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {10},
pages = {26},
doi = {10.1167/iovs.65.10.26}
}
EUVIMED